Report cover image

Global Antiviral Drug Packaging Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 190 Pages
SKU # APRC20563532

Description

Summary

According to APO Research, The global Antiviral Drug Packaging market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antiviral Drug Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antiviral Drug Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Antiviral Drug Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antiviral Drug Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antiviral Drug Packaging include Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antiviral Drug Packaging, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Antiviral Drug Packaging, also provides the sales of main regions and countries. Of the upcoming market potential for Antiviral Drug Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antiviral Drug Packaging sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Antiviral Drug Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Antiviral Drug Packaging sales, projected growth trends, production technology, application and end-user industry.

Antiviral Drug Packaging Segment by Company

Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc
BioCote
Avient
Mondi
Biomaster
BASF
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.
Antiviral Drug Packaging Segment by Type

Rigid Plastic
Flexible Blister Foils
Others
Antiviral Drug Packaging Segment by Application

Pharmaceuticals
Healthcare
Antiviral Drug Packaging Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiviral Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Drug Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antiviral Drug Packaging in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiviral Drug Packaging sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Antiviral Drug Packaging Market by Type
1.2.1 Global Antiviral Drug Packaging Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Rigid Plastic
1.2.3 Flexible Blister Foils
1.2.4 Others
1.3 Antiviral Drug Packaging Market by Application
1.3.1 Global Antiviral Drug Packaging Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Antiviral Drug Packaging Market Dynamics
2.1 Antiviral Drug Packaging Industry Trends
2.2 Antiviral Drug Packaging Industry Drivers
2.3 Antiviral Drug Packaging Industry Opportunities and Challenges
2.4 Antiviral Drug Packaging Industry Restraints
3 Global Market Growth Prospects
3.1 Global Antiviral Drug Packaging Revenue Estimates and Forecasts (2020-2031)
3.2 Global Antiviral Drug Packaging Revenue by Region
3.2.1 Global Antiviral Drug Packaging Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Antiviral Drug Packaging Revenue by Region (2020-2025)
3.2.3 Global Antiviral Drug Packaging Revenue by Region (2026-2031)
3.2.4 Global Antiviral Drug Packaging Revenue Market Share by Region (2020-2031)
3.3 Global Antiviral Drug Packaging Sales Estimates and Forecasts 2020-2031
3.4 Global Antiviral Drug Packaging Sales by Region
3.4.1 Global Antiviral Drug Packaging Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Antiviral Drug Packaging Sales by Region (2020-2025)
3.4.3 Global Antiviral Drug Packaging Sales by Region (2026-2031)
3.4.4 Global Antiviral Drug Packaging Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Antiviral Drug Packaging Revenue by Manufacturers
4.1.1 Global Antiviral Drug Packaging Revenue by Manufacturers (2020-2025)
4.1.2 Global Antiviral Drug Packaging Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Antiviral Drug Packaging Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Antiviral Drug Packaging Sales by Manufacturers
4.2.1 Global Antiviral Drug Packaging Sales by Manufacturers (2020-2025)
4.2.2 Global Antiviral Drug Packaging Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Antiviral Drug Packaging Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Antiviral Drug Packaging Sales Price by Manufacturers (2020-2025)
4.4 Global Antiviral Drug Packaging Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Antiviral Drug Packaging Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Antiviral Drug Packaging Manufacturers, Product Type & Application
4.7 Global Antiviral Drug Packaging Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Antiviral Drug Packaging Market CR5 and HHI
4.8.2 2024 Antiviral Drug Packaging Tier 1, Tier 2, and Tier 3
5 Antiviral Drug Packaging Market by Type
5.1 Global Antiviral Drug Packaging Revenue by Type
5.1.1 Global Antiviral Drug Packaging Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Antiviral Drug Packaging Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Antiviral Drug Packaging Revenue Market Share by Type (2020-2031)
5.2 Global Antiviral Drug Packaging Sales by Type
5.2.1 Global Antiviral Drug Packaging Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Antiviral Drug Packaging Sales by Type (2020-2031) & (k units)
5.2.3 Global Antiviral Drug Packaging Sales Market Share by Type (2020-2031)
5.3 Global Antiviral Drug Packaging Price by Type
6 Antiviral Drug Packaging Market by Application
6.1 Global Antiviral Drug Packaging Revenue by Application
6.1.1 Global Antiviral Drug Packaging Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Antiviral Drug Packaging Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Antiviral Drug Packaging Revenue Market Share by Application (2020-2031)
6.2 Global Antiviral Drug Packaging Sales by Application
6.2.1 Global Antiviral Drug Packaging Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Antiviral Drug Packaging Sales by Application (2020-2031) & (k units)
6.2.3 Global Antiviral Drug Packaging Sales Market Share by Application (2020-2031)
6.3 Global Antiviral Drug Packaging Price by Application
7 Company Profiles
7.1 Avery Dennison Corporation
7.1.1 Avery Dennison Corporation Comapny Information
7.1.2 Avery Dennison Corporation Business Overview
7.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio
7.1.5 Avery Dennison Corporation Recent Developments
7.2 E.I. du Pont de Nemours
7.2.1 E.I. du Pont de Nemours Comapny Information
7.2.2 E.I. du Pont de Nemours Business Overview
7.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio
7.2.5 E.I. du Pont de Nemours Recent Developments
7.3 CCL Industries Inc
7.3.1 CCL Industries Inc Comapny Information
7.3.2 CCL Industries Inc Business Overview
7.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio
7.3.5 CCL Industries Inc Recent Developments
7.4 BioCote
7.4.1 BioCote Comapny Information
7.4.2 BioCote Business Overview
7.4.3 BioCote Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BioCote Antiviral Drug Packaging Product Portfolio
7.4.5 BioCote Recent Developments
7.5 Avient
7.5.1 Avient Comapny Information
7.5.2 Avient Business Overview
7.5.3 Avient Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Avient Antiviral Drug Packaging Product Portfolio
7.5.5 Avient Recent Developments
7.6 Mondi
7.6.1 Mondi Comapny Information
7.6.2 Mondi Business Overview
7.6.3 Mondi Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Mondi Antiviral Drug Packaging Product Portfolio
7.6.5 Mondi Recent Developments
7.7 Biomaster
7.7.1 Biomaster Comapny Information
7.7.2 Biomaster Business Overview
7.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Biomaster Antiviral Drug Packaging Product Portfolio
7.7.5 Biomaster Recent Developments
7.8 BASF
7.8.1 BASF Comapny Information
7.8.2 BASF Business Overview
7.8.3 BASF Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 BASF Antiviral Drug Packaging Product Portfolio
7.8.5 BASF Recent Developments
7.9 Lonza
7.9.1 Lonza Comapny Information
7.9.2 Lonza Business Overview
7.9.3 Lonza Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Lonza Antiviral Drug Packaging Product Portfolio
7.9.5 Lonza Recent Developments
7.10 Takex Labo Co. Ltd
7.10.1 Takex Labo Co. Ltd Comapny Information
7.10.2 Takex Labo Co. Ltd Business Overview
7.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio
7.10.5 Takex Labo Co. Ltd Recent Developments
7.11 Berry
7.11.1 Berry Comapny Information
7.11.2 Berry Business Overview
7.11.3 Berry Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Berry Antiviral Drug Packaging Product Portfolio
7.11.5 Berry Recent Developments
7.12 Lageen Tubes.
7.12.1 Lageen Tubes. Comapny Information
7.12.2 Lageen Tubes. Business Overview
7.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio
7.12.5 Lageen Tubes. Recent Developments
8 North America
8.1 North America Antiviral Drug Packaging Market Size by Type
8.1.1 North America Antiviral Drug Packaging Revenue by Type (2020-2031)
8.1.2 North America Antiviral Drug Packaging Sales by Type (2020-2031)
8.1.3 North America Antiviral Drug Packaging Price by Type (2020-2031)
8.2 North America Antiviral Drug Packaging Market Size by Application
8.2.1 North America Antiviral Drug Packaging Revenue by Application (2020-2031)
8.2.2 North America Antiviral Drug Packaging Sales by Application (2020-2031)
8.2.3 North America Antiviral Drug Packaging Price by Application (2020-2031)
8.3 North America Antiviral Drug Packaging Market Size by Country
8.3.1 North America Antiviral Drug Packaging Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Antiviral Drug Packaging Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Antiviral Drug Packaging Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Antiviral Drug Packaging Market Size by Type
9.1.1 Europe Antiviral Drug Packaging Revenue by Type (2020-2031)
9.1.2 Europe Antiviral Drug Packaging Sales by Type (2020-2031)
9.1.3 Europe Antiviral Drug Packaging Price by Type (2020-2031)
9.2 Europe Antiviral Drug Packaging Market Size by Application
9.2.1 Europe Antiviral Drug Packaging Revenue by Application (2020-2031)
9.2.2 Europe Antiviral Drug Packaging Sales by Application (2020-2031)
9.2.3 Europe Antiviral Drug Packaging Price by Application (2020-2031)
9.3 Europe Antiviral Drug Packaging Market Size by Country
9.3.1 Europe Antiviral Drug Packaging Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Antiviral Drug Packaging Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Antiviral Drug Packaging Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Antiviral Drug Packaging Market Size by Type
10.1.1 China Antiviral Drug Packaging Revenue by Type (2020-2031)
10.1.2 China Antiviral Drug Packaging Sales by Type (2020-2031)
10.1.3 China Antiviral Drug Packaging Price by Type (2020-2031)
10.2 China Antiviral Drug Packaging Market Size by Application
10.2.1 China Antiviral Drug Packaging Revenue by Application (2020-2031)
10.2.2 China Antiviral Drug Packaging Sales by Application (2020-2031)
10.2.3 China Antiviral Drug Packaging Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Antiviral Drug Packaging Market Size by Type
11.1.1 Asia Antiviral Drug Packaging Revenue by Type (2020-2031)
11.1.2 Asia Antiviral Drug Packaging Sales by Type (2020-2031)
11.1.3 Asia Antiviral Drug Packaging Price by Type (2020-2031)
11.2 Asia Antiviral Drug Packaging Market Size by Application
11.2.1 Asia Antiviral Drug Packaging Revenue by Application (2020-2031)
11.2.2 Asia Antiviral Drug Packaging Sales by Application (2020-2031)
11.2.3 Asia Antiviral Drug Packaging Price by Application (2020-2031)
11.3 Asia Antiviral Drug Packaging Market Size by Country
11.3.1 Asia Antiviral Drug Packaging Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Antiviral Drug Packaging Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Antiviral Drug Packaging Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Antiviral Drug Packaging Market Size by Type
12.1.1 SAMEA Antiviral Drug Packaging Revenue by Type (2020-2031)
12.1.2 SAMEA Antiviral Drug Packaging Sales by Type (2020-2031)
12.1.3 SAMEA Antiviral Drug Packaging Price by Type (2020-2031)
12.2 SAMEA Antiviral Drug Packaging Market Size by Application
12.2.1 SAMEA Antiviral Drug Packaging Revenue by Application (2020-2031)
12.2.2 SAMEA Antiviral Drug Packaging Sales by Application (2020-2031)
12.2.3 SAMEA Antiviral Drug Packaging Price by Application (2020-2031)
12.3 SAMEA Antiviral Drug Packaging Market Size by Country
12.3.1 SAMEA Antiviral Drug Packaging Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Antiviral Drug Packaging Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Antiviral Drug Packaging Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Antiviral Drug Packaging Value Chain Analysis
13.1.1 Antiviral Drug Packaging Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Antiviral Drug Packaging Production Mode & Process
13.2 Antiviral Drug Packaging Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Antiviral Drug Packaging Distributors
13.2.3 Antiviral Drug Packaging Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.